Harm Reduction

Harm reduction refers to a set of strategies that reduce the harms associated with substance use. By meeting people where they are, harm reduction providers build trust with people who use drugs (PWUD), equipping them with the tools and information to protect themselves from infectious diseases and overdose.

Syringe services programs (SSPs) are an effective, safe, and cost-saving strategy to prevent the spread of HIV and viral hepatitis. Comprehensive SSPs offer syringe distribution and disposal, conduct education and counseling, and provide or refer clients to HIV, STI, hepatitis, and substance use disorder services. They may also distribute the overdose reversal medication naloxone, fentanyl test strips, condoms, or other supplies to prevent infectious diseases or overdose.

Local health departments (LHDs) play a critical role in providing and supporting harm reduction services. NACCHO supports LHDs by increasing buy-in, facilitating peer learning and engagement, and providing technical and capacity building assistance for harm reduction programs.

NACCHO launched the Harm Reduction Community of Practice (CoP) to increase the capacity of LHDs to implement or scale up SSPs and other harm reductions strategies. Harm Reduction CoP members meet bimonthly and calls focus on sharing the latest harm reduction-related news, information, and science; providing updates from the national and local levels; highlighting best practices and innovative strategies; and discussing challenges and opportunities related to local harm reduction efforts. If your health department is interested in joining the Harm Reduction CoP, contact Kat Kelley, Senior Program Analyst, at kkelley@naccho.org.

The National Association of County and City Health Officials (NACCHO), in partnership with the University of Washington (UW), is recruiting syringe services programs (SSPs), local health departments (LHDs), and other harm reduction stakeholders to participate in the SSP Monitoring & Evaluation Advisory Group (SSPAG). The SSPAG will work with NACCHO, UW, and partners to increase the capacity of LHDs to establish and work with SSPs, promote monitoring and evaluation (M&E) of SSPs and the use of data for SSP program improvement, and assess trends in SSP operations and injection drug use.

Participants will provide input and guidance to NACCHO and/or UW through group or individual calls or email-based requests for information with an expected time commitment of 1-2 hours per month between January and December 2021. For more information or to apply, visit here. Contact Kat Kelley, Senior Program Analyst, HIV, STI, & Viral Hepatitis at kkelley@naccho.org with any questions.

To support our growing harm reduction portfolio, NACCHO is launching a new listserv where we’ll share harm reduction opportunities, resources, news, information, and evidence-based science. Sign up here to be the first to know about NACCHO’s forthcoming funding and technical and capacity building assistance opportunities.

For additional opportunities to engage with NACCHO’s HIV, STI, & Viral Hepatitis team, visit here. For additional information on NACCHO’s Injury and Violence Prevention program, visit here.

  • HIV, STI, & Viral Hepatitis

National Substance Abuse Prevention Month: Harm...

October is National Substance Abuse Prevention Month, an opportunity to...

Oct 22, 2020 | Shalesha Majors

National Substance Abuse Prevention Month: Harm...

  • COVID-19
  • HIV, STI, & Viral Hepatitis

Syringe Services Programs and the COVID-19 Pandemic:...

Local health departments (LHDs) are on the frontlines of the opioid crisis,...

Jun 16, 2020 | Julia Zigman

Syringe Services Programs and the COVID-19 Pandemic:...

The work of local health departments (LHDs) has been severely impacted since the onset of the COVID-19 pandemic. Much of their staff has been activated as part of an emergency response to combat the virus, and many of their day-to-day activities have been suspended or are operating at a reduced capacity. Read more about the impact of COVID-19 on HIV, STI, viral hepatitis, and overdose response activities at at LHDs in our below Reports from the Field.

In the wake of the 2015 HIV outbreak in Scott County, Indiana – and in response to the Centers for Disease Control and Prevention’s (CDC’s) vulnerability assessment, which identified 220 counties most vulnerable to an outbreak of hepatitis C and HIV among PWID – the LENOWISCO Health District of the Virginia Department of Health initiated efforts to develop a comprehensive community response plan to address this vulnerability. The District, made up of four localities in rural southwest Virginia - Lee, Norton, Wise, and Scott - has been heavily impacted by the opioid epidemic and two of its counties were identified in the CDC’s assessment.

Read Community Response Planning for Outbreaks of Hepatitis and HIV Among People Who Inject Drugs: A Case Study from the LENOWISCO Health District, a Rural Community in Virginia to learn about the process the health department took for developing the Community Response Plan, lessons learned, and next steps for putting the plan into action. The full document is 138 pages, but each component can be individually accessed below:

On April 10, 2018, NACCHO hosted a webinar with the LENOWISCO Health District, titled “Developing a Community Response Plan for an Outbreak of Hepatitis and HIV among Persons Who Inject Drugs: How a Rural Community in Virginia is Preparing for and Addressing this Vulnerability.” During the webinar, staff from the health department share the process they undertook to develop the Hepatitis and HIV Community Response Plan and respond to questions from participants.

In November 2017, the Urban Coalition for HIV/AIDS Prevention Services (UCHAPS) and NACCHO held a webinar discussion on improving drug user health though syringe service programs (SSPs) in urban and rural settings.

Watch the recording.

Back to Top